PT - JOURNAL ARTICLE AU - Philipp Wendland AU - Vanessa Schmitt AU - Jörg Zimmermann AU - Lukas Häger AU - Siri Göpel AU - Christof Schenkel-Häger AU - Maik Kschischo TI - Machine learning models for predicting severe COVID-19 outcomes in hospitals AID - 10.1101/2022.10.28.22281646 DP - 2023 Jan 01 TA - medRxiv PG - 2022.10.28.22281646 4099 - http://medrxiv.org/content/early/2023/01/30/2022.10.28.22281646.short 4100 - http://medrxiv.org/content/early/2023/01/30/2022.10.28.22281646.full AB - The aim of this observational retrospective study is to improve early risk stratification of hospitalized Covid-19 patients by predicting in-hospital mortality, transfer to intensive care unit (ICU) and mechanical ventilation from electronic health record data of the first 24 hours after admission. Our machine learning model predicts in-hospital mortality (AUC=0.918), transfer to ICU (AUC=0.821) and the need for mechanical ventilation (AUC=0.654) from a few laboratory data of the first 24 hours after admission. Models based on dichotomous features indicating whether a laboratory value exceeds or falls below a threshold perform nearly as good as models based on numerical features. We devise completely data-driven and interpretable machine-learning models for the prediction of in-hospital mortality, transfer to ICU and mechanical ventilation for hospitalized Covid-19 patients within 24 hours after admission. Numerical values of CRP and blood sugar and dichotomous indicators for increased partial thromboplastin time (PTT) and glutamic oxaloacetic transaminase (GOT) are amongst the best predictors.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was part of the project 'Ein Global-Trigger-Tool fuer COVID-19-bedingte Schwerstschadenereignisse in Krankenhaeusern' (A global trigger tool for Covid-19-caused sentinel events in hospitals) funded by the Ministerium fuer Wissenschaft und Gesundheit Rheinland-Pfalz, Deutschland (Ministry of Sciences and Health of Rhineland-Palatinate, Germany).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of the University of Applied Sciences Koblenz gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRaw data can not made available because of German and EU data privacy regulations.